Study: Rapid Adoption Noted for Kanjinti During First Year of Availability

Retrieved on: 2021-03-18 15:56:15

Tags for this article:

Life Sciences

Health

Metastatic breast cancer

Trastuzumab emtansine

National Comprehensive Cancer Network

Click the tags to see associated articles and topics

Study: Rapid Adoption Noted for Kanjinti During First Year of Availability. View article details on hiswai:

Excerpt

They used Flatiron Health retrospective data to develop 2 patient cohorts: those with early breast cancer (eBC, n = 2149) and those with metastatic ...

Article found on: www.centerforbiosimilars.com

View Original Article